Featured Posts
Wall Street Journal
A Thumb on the Scale for Wegovy
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid…
Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…
News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
Search Posts
Wall Street Journal
The FDA Wants to Interfere in the Practice of Medicine
Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians routinely prescribe…
City Journal
PODCAST: The Last Gasp of Pandemic Restrictions?
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the “tripledemic” of Covid, flu and RSV, the relationship of public health and…
City Journal
Ignore the “Tripledemic” Hype
Winter is back, and so are warnings from “experts” for Americans to don masks. A resurgence of influenza (flu) and respiratory syncytial virus (RSV)—respiratory illnesses…
National Review
Senate, Forget about Rolling Back the Government Takeover of Health Care
Elections have consequences. Republicans’ failure to capture the U.S. Senate means that the Senate Committee on Health, Education, Labor, and Pensions — known as the HELP…
City Journal
End the Vaccine Mandates
One year ago, the Center for Medicare & Medicaid Services (CMS) issued an interim final rule requiring 15 types of health-care facilities that…
The New York Post
Biden Wastes Billions on COVID Boosters No One Wants
When it comes to wasting money, the Biden administration has few peers. Earlier in the year, Team Biden re-purposed billions of dollars to buy 170…